ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

Report Urges Heated Chemo To Optimize Patient Survival

November 24, 2006

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

December 5, 2014

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

March 21, 2008